NCCN Urothelial Cancer Practice Guidelines

ONCOLOGY

Volumn 12, Issue 7 A, 1998, Pages 225-271

  Scher, Howard ^a   Bahnson, Robert ^b   Cohen, Samuel ^c   Eisenberger, Mario ^d   Herr, Harry ^a   Kozlowski, James ^e   Lange, Paul ^f   Montie, James ^g   Pollack, Alan ^h   Raghaven, Derek ⁱ   Richie, Jerome ^j   Shipley, William ^k  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ ROSWELL PARK CANCER INSTITUTE   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; CANCER DIAGNOSIS; CANCER THERAPY; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; UROGENITAL TRACT CANCER;

HUMANS; KIDNEY NEOPLASMS; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0344843277     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)

1. Braun EV, Ah M, Fayemi AO, et al Primary signet-ring cell carcinoma of the urinary bladder: Review of the literature and report of a case. Cancer 47:1430-1435, 1981.
2. Brodsky GL: Pathology of bladder carcinoma. Hematol Oncol Clin North Am 6:59-80, 1992.
3. Cervak J, Cufer T, Marolt F, et al: Combined chemotherapy and radiotherapy in muscle-invasive bladder carcinoma: Complete remission results (abstract) Proceedings of the European Cancer Conference 6:561, 1991.
4. Crawford ED, Natale RB, Burton H. South-west Oncology Group Study (8710): Trial of cystectomy alone versus neo-adjuvant M-VAC and cystectomy in patients with locally advanced bladder cancer (Intergroup Trial 0080). Prog Clin Biol Res 353:111-114, 1991.
5. Farah R, Chodak GW, Vogclzang NJ, et al Curative radiotherapy after chemotherapy for invasive bladder carcinoma (a preliminary report). int J Radiat Oncol Biol Phys 20:413-417, 1991.
6. Fung CY, Shipley WU, Young RH, et al: Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J Clin Oncol 9:1533-1542, 1991.
7. GISTV (Italian Bladder Cancer Study Group), Pelligrini A: Neoadjuvant treatment for locally advanced bladder cancer: A randomized prospective clinical trial (abstract). Fourth International Symposium on Advances in Urologie Oncology 5:11, 1993.
8. Given RW, Parsons JT, McCarley D, et al: Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: A 5-year follow up. Urology 46:499-505, 1995.
9. Gospodarowicz MK, Hawkins NV, Rawlings GA, et al: Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: Failure and analysis. J Urol 142:1448-1454,1989.
10. Hall RR, Newling DW, Ramsden PD, et al: Treatment of invasive bladder cancer by local resection and high dose methotrexate. Br J Urol 56:668-672, 1984.
11. Hall RR: Neoadjuvant CMV chemotherapy and cystectomy or radiotherapy in muscle invasive bladder cancer : First analysis of MRC/EORTC intercontinental trial (abstract 612). Proc Am Soc Clin Oncol 15:244, 1996.
12. Hall RR, Parmar MKB, Richards AB, et al. Changes in cystoscopic follow up in patients with bladder cancer and adjuvant intravesical chemotherapy. Br Med J 308:257-260, 1994.
13. Hall RR, Roberts JT: Neoadjuvant chemotherapy, a method to conserve the bladder? (abstract). Proceedings of the European Cancer Conference 6:144, 1991.
14. Harker W, Meyers FJ, Freiha FS, et al: Cisplatin, methotrexate, and vinblastine (CMV): An effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract: A Northern California Oncology Group study. J Clin Oncol 3:1463-1470, 1985.
15. Herr HW, Scher HI: Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. J Clin Oncol 12:975-980, 1994.
16. 15a, Housset M, Maulard C, Chretien YC, et al: Combined radiation and chemotherapy for invasive transitional cell carcinoma of the bladder. J Clin Oncol 11:2150-2157, 1993.
17. Jenkins BJ, Blandy JP, Caulfield MJ, et al: Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive bladder cancer. Br J Urol 62:343-346, 1988.
18. Jewett HJ, Strong GH: Infiltrating carcinoma of the bladder: Relation of depth of penetration of the bladder wall to incidence of local extension in metastases. J Urol 55:366, 1946
19. Kakizoe T, Matsumoto K, Andoh M, et al. Adenocarcinoma of urachus: Report of 7 cases and review of literature Urology 21:360-366, 1983.
20. Kata EJ, Herr H The role of transurethral resection for muscle invasive bladder carcinoma (abstract). J Urol 149:316A, 1993.
21. Kaufman DS, Shipley WU, Althausen AF Radiotherapy and chemotherapy in invasive bladder cancer with potential bladder sparing. Hematol Oncol Clin North Am 6:179-194, 1992.
22. 20a. Shipley WU, Winter KA, Lee R, et al: Initial results of RTOG 89-03. A phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy (Proc Am Soc Ther Radiol Oncol abstract 41). Int J Radiat Oncol Biol Phys 30(2): 1997.
23. 20b.Kachnic LA, Kaufman DS, Heney NM, et al: Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 15:1022-1029, 1997.
24. Keating JP, Zincke H, Hahn RG, et al Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 NO MO transitional cell carcinoma of the urinary bladder. Prog Clin Biol Res 353:119-127, 1990.
25. Kim B, Semelka RC, Ascher SM, et al Bladder tumor staging: Comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enchanced imaging, and late gadolinium-enhancing imaging. Radiology 193:239-245, 1994.
26. Koiso K, Shipley W, Keuppens F, et al: The status of bladder preserving therapeutic strategies in the management of patients with muscle invasive bladder cancer. Int J Urol 2:49-57,1995.
27. Kurth KII, Splinter TA, Jacqmin D, et al: Transitional cell carcinoma of the bladder: A phase II study of chemotherapy in T3-4 NO MO of the EORTC GU group, in Alderson AR, Oliver RT, Hanham IW, et al (eds): Urological Oncology Dilemmas and Developments, pp 115-128. New York, Wiley Liss, 1991
28. Logothetis C, Swanson D, Amato R, et al: Optimal delivery of perioperative chemotherapy: Preliminary results of randomized, prospective, comparative trial of preoperative and postoperative chemotherapy for invasive bladder carcinoma. J Urol 155:1241-1245, 1996.
29. Maffezzim M, Torelli T, Villa E, et al: Systemic preoperative chemotherapy with cisplatin, methotrexate, and vinblastine for locally advanced bladder cancer. J Urol 145:741-743, 1991.
30. Montie JE, Straffon RA, Stewart BH: Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol 131:477-482, 1984.
31. National Board of Health and Welfare: Cancer Incidence in Sweden in 1985. Stockholm, National Board of Health and Welfare, 1989.
32. Pagano F, Bassi P, Galetti TP, et al Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 145:45-50, 1991.
33. Parker SL, Tong T, Bolden S, et al: Cancer statistics. 1997. CA Cancer J Clin 47:5-27, 1997.
34. Parsons JT, Million RR. Bladder cancer, in Perez CA, Brady IW (eds): Principles and Practice of Radiation Oncology, pp 1036-1058. Philadelphia, Lippincott, 1991.
35. Prout GR Jr, Shipley WU, Kaufinan DS, et al: Preliminary results in invasive bladder cancer with J transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy. J Urol 144:1128-1134, 1990.
36. Quility P, Duncan W: Primary radical radiotherapy for T3 transitional cell cancer of the bladder: An analysis of survival and control. Int J Radiat Oncol Biol Phys 12:853-860, 1986
37. Reuter V: Pathology of bladder cancer: Assessments of prognostic variables and response to therapy. Semin Oncol 17:524-532, 1990.
38. Rintala E, Hannisdal E, Fossa SD, et al: Neoadjuvant chemotherapy in bladder cancer: A randomized study: Nordic Cystectomy Trial 1. Scand J Urol Nephrol 27:355-362, 1993.
39. Scher H, Herr H, Sternberg C, et al: Neoadjuvant chemotherapy for invasive bladder cancer: Experience with the M-VAC regimen. Br J oral 64:250-256, 1989.
40. Scher HI: Chemotherapy for invasive bladder cancer: Neoadjuvant versus adjuvant. Semin Oncol 17:555-565, 1990.
41. Skinner DG, Lieskovsky G: Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in the management of invasive bladder cancer. J Urol 131:1069-1072, 1984.
42. Skipper HE: Historic milestones in cancer biology: A few that are important in cancer treatment (revisited). Semin Oncol 6(4):506-514, 1979.
43. Smaaland R, Akslen LA, Tonder B, et al: Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients. Br J Urol 67:61-69, 1991.
44. Sternberg CN, Yagoda A, Scher HI, et al: Preliminary results of methotrexate, vinblastine, Adriamycin and cisplatin (M-VAC) in advanced urothelial tumors. J Urol 133:403-407, 1985.
45. Sweeney P, Kursh ED, Resnick MI: Partial cystectomy. Urol Clin North Am 19:701-711, 1993.
46. Tanimoto A, Yuasa Y, Imai Y, et al: Bladder tumor staging: Comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT. Radiology 185:741-747, 1992.
47. Tester W, Porter A, Heaney J, et al: Neoadjuvant combined modality therapy with possible organ preservation for invasive bladder cancer J Clin Oncol 14:119-126, 1996.
48. Wallace DM, Raghavan D, Kelly KA, et al: Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. Br J Urol 67:608-615, 1991.
49. Whitmore WF: Management of invasive bladder neoplasms. Semin Urol 1:4-10, 1983.